The Beauty Health Company (SKIN) Financial Statements (2025 and earlier)
Company Profile
| Business Address |
2165 SPRING STREET LONG BEACH, CA 90806 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 3841 - Surgical and Medical Instruments and Apparatus (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 9/30/2024 MRQ | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 523,025 | 568,197 | 901,886 | 3,265 | |||
| Cash and cash equivalents | 523,025 | 568,197 | 901,886 | 3,265 | |||
| Receivables | 55,029 | 77,774 | 51,423 | ||||
| Inventory, net of allowances, customer advances and progress billings | 91,321 | 116,430 | 35,261 | ||||
| Inventory | 91,321 | 116,430 | 35,261 | ||||
| Prepaid expense | 638 | ||||||
| Other undisclosed current assets | 28,877 | 26,698 | 12,322 | ||||
| Total current assets: | 698,252 | 789,099 | 1,000,892 | 3,903 | |||
| Noncurrent Assets | |||||||
| Operating lease, right-of-use asset | 12,120 | 15,637 | 14,992 | ||||
| Long-term investments and receivables | 460,098 | ||||||
| Long-term investments | 460,098 | ||||||
| Intangible assets, net (including goodwill) | 187,941 | 170,979 | 179,704 | ||||
| Goodwill | 125,818 | 124,593 | 123,694 | ||||
| Intangible assets, net (excluding goodwill) | 62,123 | 46,386 | 56,010 | ||||
| Deferred income tax assets | 531 | 815 | 330 | ||||
| Other noncurrent assets | 16,043 | 14,193 | 6,705 | ||||
| Other undisclosed noncurrent assets | 14,226 | 18,184 | 16,183 | ||||
| Total noncurrent assets: | 230,861 | 219,808 | 217,914 | 460,098 | |||
| TOTAL ASSETS: | 929,113 | 1,008,907 | 1,218,806 | 464,001 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities | 64,614 | 45,518 | 72,725 | 765 | |||
| Taxes payable | ✕ | ✕ | ✕ | 292 | |||
| Employee-related liabilities | ✕ | ✕ | ✕ | 28,662 | 12 | ||
| Accounts payable | 44,768 | 30,335 | 29,049 | ||||
| Accrued liabilities | 19,846 | 15,183 | 14,722 | 754 | |||
| Other undisclosed current liabilities | 50,394 | 27,597 | 3,712 | ||||
| Total current liabilities: | 115,008 | 73,115 | 76,437 | 765 | |||
| Noncurrent Liabilities | |||||||
| Long-term debt and lease obligation | 738,372 | 734,143 | 742,695 | ||||
| Long-term debt, excluding current maturities | 738,372 | 734,143 | 729,914 | ||||
| Liabilities, other than long-term debt | 14,788 | 14,700 | 3,561 | 16,100 | |||
| Accounts payable and accrued liabilities | 2,000 | ||||||
| Deferred compensation liability, classified | 16,100 | ||||||
| Deferred income tax liabilities | 702 | 2,011 | 3,561 | ||||
| Other liabilities | 2,767 | ||||||
| Operating lease, liability | 9,319 | 12,689 | 12,781 | ||||
| Other undisclosed noncurrent liabilities | 1,555 | 15,473 | 93,816 | 65,647 | |||
| Total noncurrent liabilities: | 754,715 | 764,316 | 840,072 | 81,747 | |||
| Total liabilities: | 869,723 | 837,431 | 916,509 | 82,512 | |||
| Temporary equity, carrying amount | 376,489 | ||||||
| Equity | |||||||
| Equity, attributable to parent, including: | 59,390 | 171,476 | 302,297 | 5,000 | |||
| Common stock | 12 | 14 | 16 | ||||
| Additional paid in capital | 541,281 | 550,320 | 722,250 | 43,912 | |||
| Accumulated other comprehensive loss | (3,036) | (4,530) | (1,257) | ||||
| Accumulated deficit | (478,867) | (374,328) | (418,712) | (38,914) | |||
| Other undisclosed equity, attributable to parent | 2 | ||||||
| Total equity: | 59,390 | 171,476 | 302,297 | 5,000 | |||
| TOTAL LIABILITIES AND EQUITY: | 929,113 | 1,008,907 | 1,218,806 | 464,001 | |||
Income Statement (P&L) ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|---|
| Revenues | 397,991 | 365,876 | 260,086 | |||
| Cost of revenue | (242,878) | (115,536) | (78,259) | |||
| Gross profit: | 155,113 | 250,340 | 181,827 | |||
| Operating expenses | (286,030) | (274,620) | (218,466) | |||
| Operating loss: | (130,917) | (24,280) | (36,639) | |||
| Nonoperating income (expense) | 30,758 | (4,814) | (340,711) | |||
| Investment income, nonoperating | 23,173 | |||||
| Gain (loss), foreign currency transaction, before tax | 2,385 | (3,164) | (69) | |||
| Other nonoperating income (expense) | 5,200 | (1,650) | (4,450) | |||
| Interest and debt expense | (13,649) | (2,300) | ||||
| Loss from continuing operations before equity method investments, income taxes: | (113,808) | (29,094) | (379,650) | |||
| Other undisclosed income from continuing operations before income taxes | 11,919 | 74,126 | 2,300 | |||
| Income (loss) from continuing operations before income taxes: | (101,889) | 45,032 | (377,350) | |||
| Income tax expense (benefit) | 1,773 | (648) | 2,242 | |||
| Income (loss) from continuing operations: | (100,116) | 44,384 | (375,108) | |||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | (375,108) | ✕ | |
| Net income (loss) available to common stockholders, basic: | (100,116) | 44,384 | (375,108) | |||
| Dilutive securities, effect on basic earnings per share | ||||||
| Other undisclosed net loss available to common stockholders, diluted | (78,343) | |||||
| Net loss available to common stockholders, diluted: | (100,116) | (33,959) | (375,108) | |||
Comprehensive Income ($ in thousands)
| 9/30/2024 TTM | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | ||
|---|---|---|---|---|---|---|
| Net income (loss): | (100,116) | 44,384 | (375,108) | |||
| Comprehensive income (loss): | (100,116) | 44,384 | (375,108) | |||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | 1,494 | (3,273) | (1,499) | |||
| Comprehensive income (loss), net of tax, attributable to parent: | (98,622) | 41,111 | (376,607) | |||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.